In this groundbreaking interview, Dr. John Catanzaro (CEO of Neo7Bioscience) joins Dr. Peter McCullough and epidemiologist Nicolas Hulscher to present new molecular data on patients impacted by COVID-19 mRNA vaccination. A joint investigation by Neo7Bioscience and the University of North Texas Genomics & Biodiscovery Institute reveals a concerning pattern of biological disruption. Click Here to Go to Full Video Interview
Using the REViSS platform—RNA Expression Variant Instability Signature Surveillance—researchers analyzed peripheral blood samples from real-world patients to assess hallmark gene expression, detect synthetic RNA fragments, and identify dysregulated signaling pathways associated with immune dysfunction and cancer progression.
The results support mounting evidence of reverse transcription, immune destabilization, and tumor-promoting gene dysregulation in mRNA-injected individuals.